Neurological disorders and head injuries

Substance Abuse in the Mentally and Physically Disabled

Volumn , Issue , 2001, Pages 277-306

  Weinstein, David D ^a   Martin, Peter R ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 37449028630     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (200)

1. C Jackson. The Lost Weekend. New York: Farrar & Reinhart, p 233, 1944.
2. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Press, 1994.
3. DM Sosin, JE Sniezek, RJ Waxweiler. Trends in death associated with traumatic brain injury, 1979 through 1992: success and failure. JAMA 273: 1778-1780, 1995.
4. Traumatic Brain Injury-Colorado, Missouri, Oklahoma, and Utah, 1990-1993. MMWR 46(1), 1997.
5. SB Sorenson, JF Kraus. Occurrence, severity, and outcomes of brain injury. Head Trauma Rehab 6: 1-10, 1991.
6. Alcohol Alert-Drinking and Driving. NIAAA, no. 31, 1996.
7. G Li, GS Smith, SP Baker. Drinking behavior in relation to cause of death among US adults. Am J Public Health 84: 1402-1406, 1994.
8. WH Ruthford. Diagnosis of alcohol ingestion in mild head injuries. Lancet i: 1021-1023, 1977.
9. S Galbraith, AR Murray, R Knill-Jones. The relationship between alcohol and head injury and its effects on the conscious level. Br J Surg 63: 128-130, 1976.
10. R Honaken, G Smith. Impact of acute alcohol intoxication on patterns of non-fatal trauma: cause specific analysis of head injury effect. Injury 22: 225-229, 1991.
11. W Wechsler, EH Kasey, D Thum, HW Demone Jr. Alcohol level and home accidents. Public Health Rep 84: 1043-1050, 1969.
12. HW Demone Jr, EH Kasey. Alcohol and non-motor vehicle injuries. Public Health Rep 81: 585-590, 1966.
13. J Shepherd, M Irish, C Scully, L Leslie. Alcohol intoxication and severity of injury in victims of assault (brief report). Br Med J 296: 1299, 1988.
14. Eighth Special Report to the U.S. Congress on Alcohol and Health from the Secretary of Health and Human Services, Sept 1993.
15. DD Weinstein, PR Martin. Psychiatric implications of alcoholism and traumatic brain injury. Am J Addictions 4: 285-296, 1995.
16. RM Weinrieb, CP O’Brien. Persistent cognitive deficits attributed to substance abuse. In: Neurologic Complications of Drug and Alcohol Abuse. Neurol Clin 11: 663-691, 1993.
17. AJ Twerski. Substance abuse in head injury rehabilitation. Legal Med 93-108, 1992.
18. DI Graham, JH Adams, TA Gennarelli. Pathology of brain damage in head injury. In: Head Injury. 3rd ed. PR Cooper, ed. Baltimore: Williams and Wilkins, 1993.
19. TA Gennarelli. Mechanisms of cerebral concussion, contusion, and other effects of head injury. In: Neurological Surgery. 3rd ed. J Youmans, ed. Philadelphia: WB Saunders, 1990.
20. GF Gade, DP Becker, JD Miller, PS Dwan. Pathology and pathophysiology of head injury. In: Neurological Surgery. 3rd ed. Youmans JR, ed. Philadelphia: WB Saunders, 1990.
21. G Teasdale, D Mendelow. Pathophysiology of head injuries. In: Closed Head Injury: Psychological, Social, and Family Consequences. DN Brooks, ed. Oxford: Oxford University Press, 1984.
22. TA Gennarelli. Head injury in man and experimental animals: clinical aspects. Acta Neurochir 32(suppl): 1-13, 1983.
23. DD Bickle, HK Genant, C Cann, RR Recker, BP Halloran, GJ Strewler. Bone disease in alcohol abuse. Ann Intern Med 103: 42-48, 1985.
24. T Diamond, D Stiel, M Lunzer, M Wilkinson, S Posen. Ethanol reduces bone formation and may cause osteoporosis. Am J Med 86: 282-288, 1989.
25. JL Gonzalez-Calvin, A Garcia-Sanchez, V Bellot, M Munoz-Torres, E Raya-Alvarez, D Salvatierra-Rios. Mineral metabolism, osteoblastic function, and bone mass in chronic alcoholism. Alcohol Alcohol 28: 571-579, 1993.
26. A Garcia-Sanchez, JL Gonzalez-Calvin, A Diez-Ruiz, JL Casals, F Gallego-Ro-Jo, D Salvatierra. Effect of acute alcohol ingestion on mineral metabolism and osteoblastic function. Alcohol Alcohol 30: 449-453, 1995.
27. AHS Holbourn. Mechanics of head injuries. Lancet ii: 438-441, 1943.
28. JH Adams, G Scott, LS Parker, DI Graham, D Doyle. The Contusion Index: a quantitative approach to cerebral contusions in head injury. Neuropathol Appl Neurobiol 6: 319-324, 1980.
29. JH Adams, D Doyle, DI Graham, AE Lawrence, DR Mc Lellan, TA Gennerelli, M Pastuszko, T Sakamoto. The Contusion Index: a reappraisal in human and experimental non-missle head injury. Neuropathol Appl Neurobiol 11: 299-308, 1985.
30. M Sarazin, B Pillon, P Giannakopoulos, G Rancurel, Y Samson, B Dubois. Clinicometabolic dissociation of cognitive functions and social behavior in frontal lobe lesions. Neurology 51: 142-148, 1998.
31. R Formisano, B Schmidhuber-Eiler, L Saltuari, E Cigany, G Birbauer, F Gerstenbrand. Neuropsychological outcome after traumatic temporal lobe damage. Acta Neuroclin 109: 1-4, 1991.
32. TA Gennarelli. Cerebral concussion and diffuse brain injuries. In: Head Injury. 3rd ed. Cooper PR, ed. Baltimore: Williams and Wilkins, 1993.
33. TA Gennarelli, LE Thibault, JH Adams, DL Graham, CJ Thompson, RP Marcincin. Diffuse axonal injury and traumatic coma in the primate. Ann Neurol 12: 564-574, 1982.
34. JH Adams, DI Graham, LS Murry, G Scott. Diffuse axonal injury due to non-missle head injury in humans: an analysis of 45 cases. Ann Neurol 12: 557-563, 1982.
35. J Rose, S Valtonen, B Jennett. Avoidable factors contributing to death after head injury. Br Med J 2: 615-618, 1977.
36. RM Ruff, LF Marshall, MR Klauber, et al. Alcohol abuse and neurological outcome of the severely head-injured. J Head Trauma Rehab 5: 21-31, 1990.
37. O Elmér, G Göransson, E Zoucas. Impairment of primary hemostasis and platelet function after alcohol ingestion in man. Haemostsis 14: 223-228, 1984.
38. DH Cowan. The platelet defeat in alcoholism. Ann NY Acad Sci 252: 328-341, 1975.
39. DR Curtis, GAR Johnston. Amino acid transmitters in the mammalian central nervous system. Ergebnisse der Physiologie Biologischen Chemie und Experimentellen Pharmakologie 69: 98-188, 1974.
40. F Fonnum. Glutamate: a neurotransmitter in mammalian brain. J Neurochem 42: 1-11, 1984.
41. JR Cooper, FE Bloom, HR Roth. The Biochemical Basis of Neuropharmacology. 6th ed. New York: Oxford University Press, 1991.
42. JC Watkins, P Krogsgaard-Larsen, T Honore. Structure-activity relationships in the development of excitatory amino acid receptor agonists and competitive antagonists [review]. Trends Pharmacol Sci 1: 25-33, 1990.
43. AB MacDermott, ML Mayer, GL Westbrook, SJ Smith, JL Barker. NMDAreceptor activation increases cytoplasmic calcium concentration in cultural spinal cord neurones. Nature 321: 519-522, 1986.
44. DM Lovinger. Excitotoxicity and alcohol-related brain damage. Alcohol Clin Exp Res 17: 19-27, 1993.
45. A receptors. FASEB J 4: 1469-1480, 1990.
46. RA Floyd. Role of oxygen free radicals in carcinogenesis and brain ischemia. FASEB J 4: 2587-2597, 1990.
47. JT Coyle, P Puttfarken. Oxidative stress, glutamate, and neurodegenerative disorders. Science 262: 689-695, 1993.
48. A Bjørneboe, GEA Bjørneboe. Antioxidant status and alcohol-related diseases. Alcohol Alcohol 28: 111-116, 1993.
49. WA Hunt. Role of free-radical reactions in ethanol-induced brain damage: an introduction. In: Alcohol-Induced Brain Damage. Hunt WA, Nixon SJ, eds. Washington, DC: NIAAA Research Monograph 22, 1993.
50. BK Siesjö. Cell damage in the brain: a speculative syntheses. J Cereb Blood Flow Metab 1: 155-185, 1981.
51. W Young, V Yen, A Blight. Extracellular calcium ionic activity in experimental spinal cord contusion. Brain Res 253: 105-113, 1982.
52. B Meldrum, MH Millan, TP Obrenovitch. Excitatory amino acid release in- duced by injury. In: The Role of Neurotransmitters in Brain Injury. M Globus, WD Dietrich, eds. New York: Plenum, 1992.
53. R Bullock, S Butcher, D Graham, G Teasdale. Excitatory amino acid release after focal cerebral ischemia: infarct volume determines E.A.A. release. In: The Role of Neurotransmitters in Brain Injury. M Globus, WD Dietrich, eds. New York: Plenum, 1992.
54. DW Choi. Glutamate neurotoxicity in cortical cell culture is calcium-dependent. Neurosci Lett 58: 293-297, 1985.
55. DW Choi. Calcium: still center-stage in hypoxic-ischemic neuronal death. Trends Neurosci 18: 58-60, 1995.
56. SM Rothman, JW Olney. Excitotoxicity and the NMDA receptor-still lethal after eight years. Trends Neurosci 18: 57-58, 1995.
57. +2 solutions. J Neurosci 6: 3144-3151, 1986.
58. A Frandsen, AJ Shousboe. Excitatory amino acid-mediated cytotoxicity and calcium homeostasis in cultured neurons. J Neurochem 60: 1202-1211, 1993.
59. JH Williams, ML Errington, MA Lynch, TV Bliss. Arachidonic acid induces a long-term activity-dependent enhancement of synaptic transmission in the hippocampus. Nature 341: 739-742, 1989.
60. DE Pellegrini-Giampietro, G Cherici, M Alesiani, V Carla, F Moroni. Excitatory amino acid release form rat hippocampal slices as a consequence of free-radical formation. J Neurochem 51: 1960-1963, 1988.
61. FE Lancaster. Nitric oxide and ethanol-induced brain damage: a hypothesis. In: Alcohol-Induced Brain Damage. WA Hunt, SJ Nixon, eds. Washington, DC: NIAAA Research Monograph 22, 1993.
62. TJ O’Dell, RD Hawkins, ER Kandel, O Arancio. Tests of the roles of two diffusable substances in long-term potentiation: evidence for nitric oxide as a possible early retrograde messenger. Proc Natl Acad Sci USA 88: 11285-11289, 1991.
63. VL Dawson, TM Dawson, ED London, DS Bredt, SH Snyder. Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc Natl Acad Sci USA 88: 6368-6371, 1991.
64. FT Crews, LJ Chandler. Excitotoxicity and the neuropathology of ethanol. In: Alcohol-Induced Brain Damage. WA Hunt, SJ Nixon, eds. Washington, DC: NIAAA Research Monograph 22, 1993.
65. RA Harris, AM Allan. Alcohol intoxication: ion channels and genetics. FASEB J 3: 1689-1695, 1989.
66. KA Grant, P Valverins, M Hudspith, B Tabakoff. Ethanol withdrawal seizures and the NMDA receptor complex. Eur J Pharmacol 176: 289-296, 1990.
67. EK Michaelis, WJ Freed, N Galton, J Foye, ML Michaelis, I Phillips, JE Kleinman. Glutamate receptor changes in brain synaptic membranes from human alcoholics. Neurochem Res 15: 1055-1063, 1990.
68. KR Iorio, L Reinlib, B Tabakoff, PL Hoffman. Chronic exposure of cerebellar granule cells to ethanol results in increased N-methyl-D-aspartate receptor function. Mol Pharmacol 41: 1142-1148, 1992.
69. CT Smothers, JJ Mrotek, DM Lovinger. Chronic ethanol exposure leads to a selective enbardment of N-methyl-D-aspartate receptor function in cultured hippocampal neurons. J Pharmacol Exp Ther 283: 1214-1222, 1997.
70. S Dolin, H Little, M Hudspith, C Pagonis, J Littleton. Increased dihydropyridine- sensitive calcium channels in rat brain may underlie ethanol physical dependence. Neuropharmacology 26: 275-279, 1987.
71. PR Martin, BA McCool, CK Singleton. Genetic sensitivity to thiamine deficiency and development of alcoholic organic brain disease. Alcohol Clin Exp Res 17: 31-37, 1993.
72. PJ Langlais, SX Zhang. Extracellular glutamate is increased in the thalamus during thiamine deficiency-induced lesions and is blocked by MK-801. J Neurochem 61: 2175-2182, 1993.
73. MP Armanini, C Hutchins, BA Stein, RM Sapolsky. Glucocorticoid endangerment of hippocampal neurons is NMDA-receptor-dependent. Brain Res 532: 7-12, 1990.
74. SK Majumdar, GK Shaw, AD Thomson. Plasma vitamin E status in chronic alcoholic patients. Drug Alcohol Depend 12: 269-272, 1983.
75. GAE Bjørneboe, J Johnsen, A Bjørneboe, JE Bache-Wiig, J Morland, CA Drevon. Diminished serum concentration of vitamin E in alcoholics. Ann Nutr Metab 32: 56-61, 1988.
76. M Ledig, J-R M’Paria, P Mandel. Superoxide dismutase activity in rat brain during acute and chronic alcohol intoxication. Neurochem Res 6: 385-390, 1981.
77. BC Chandler, A Vega, OA Parsons. Dichotic listening in alcoholics with and without a history of possible brain injury. Q J Stud Alcohol 34: 1099-1109, 1973.
78. DA Solomon, PF Malloy. Alcohol, head injury, and neuropsychological function. Neuropsycholog Rev 3: 249-280, 1992.
79. M Oscar-Berman. The experimental analysis of cognitive deficit after head injury: perspectives from other neurological disorders and nonhuman animal research. In Neurobehavioral Recovery from Head Injury. HS Levin, J Grafman, HM Eisberg, eds. New York: Oxford University Press, pp 178-188, 1987.
80. MP Kelly, CT Johnson, N Knoller, DA Drubach, MM Winslow. Substance abuse, traumatic brain injury and neuropsychological outcome. Brain Injury 11: 391-402, 1997.
81. National Head Injury Foundation. Substance abuse task force report: white paper. Southborough, MA: NHIF, 1988.
82. ML Dombouy 1997. Tramatic brain injury. In: Principles of Neurologic Rehabilitation. RB Lazar, ed. New York: McGraw-Hill, 1997.
83. JR Hubbard, AS Everett, MA Khan. Alcohol and drug abuse in patients with physical disabilities. Am J Drug Alcohol Abuse 22(2): 215-231, 1996.
84. JD Corrigan. Substance abuse as a mediating factor in outcome from traumatic brain injury. Arch Phys Med Rehabil 76: 302-309, 1995.
85. JS Kreutzer, KR Doherty, JA Harris, et al. Alcohol use among persons with traumatic brain injury. J Head Trauma Rehab 5: 9-20, 1990.
86. T Kupke, W O’Brien. Neuropsychological impairment and behavioral limitations exhibited within an alcohol treatment program. J Clin Exp Neuropsychol 7: 292-304, 1985.
87. FR Sparadeo, D Strauss, JT Barth. The incidence, impact, and treatment of substance abuse in head trauma rehabilitation. J Head Trauma Rehab 5: 1-8, 1990.
88. WF Blackerby, A Baumgarten. A model treatment program for the head injured substance abuser: preliminary findings. J Head Trauma Rehab 5: 47-59, 1990.
89. M Langley, W Lindsay, C Lam, DA Priddy. A comprehensive alcohol abuse treatment program for persons with traumatic brain injury. Brain Injury 4: 77-86, 1990.
90. JD Corrigan, GL Lamb-Hart, E Rust. A program of intervention for substance abuse following traumatic brain injury. Brain Injury 9: 221-236, 1995.
91. RL Delmonico, P Hanley-Peterson, J Englander. Group psychotherapy for persons with traumatic brain injury: management of frustration and substance abuse. J Head Trauma Rehab 13: 10-22, 1998.
92. PA Garcia, BK Alldredge. Drug-induced seizures. In: Epilepsy II: Special Issues. Neurol Clin 12: 85-89, 1994.
93. MP Earnest. Seizures. In: Neurologic Complications of Drug and Alcohol Abuse. Neurol Clin 11: 563-575, 1993.
94. M Victor, RD Adams. The effect of alcohol on the nervous system. Res Publ Assoc Nerv Ment Dis 32: 526-573, 1953.
95. M Victor, C Brausch. The role of abstinence in the genesis of alcoholic epilepsy. Epilepsia 8: 1-20, 1967.
96. H Isbell, HF Fraser, A Wikler, et al. An experimental study of the etiology of “rum fits” and delirium tremens. Q J Stud Alcohol 16: 1-33, 1955.
97. DG McQuarrie, E Fingl. Effects of single doses and chronic administration of ethanol on experimental seizures in mice. J Pharmacol Exp Ther 124: 264-271, 1958.
98. CF Essig, RC Lam. Convulsions and hallucinatory behavior following alcohol withdrawal in the dog. Arch Neurol 18: 626-632, 1968.
99. FW Ellis, JR Pick. Ethanol-induced withdrawal reactions in rhesus monkeys. Pharmacologist 11: 256, 1969.
100. FW Ellis, JR Pick. Experimentally induced ethanol dependence in rhesus monkeys. J Pharmac Exp Ther 175: 88-93, 1970.
101. M Victor. Alcohol withdrawal seizures: an overview. In: Alcohol and Seizures: Basic Mechanisms and Clinical Concepts. RJ Porter, RH Mattson, JA Cramer, I Diamond, eds. Philadelphia: FA Davis, 1990.
102. M Victor. Summary: questions answered and unanswered. In: Alcohol and Seizures: Basic Mechanisms and Clinical Concepts. RJ Porter, RH Mattson, JA Cramer, I Diamond, eds. Philadelphia: FA Davis, 1990.
103. N Delanty, CJ Vaughan, JA French. Medical causes of seizures. Lancet 352: 383-390, 1998.
104. FG Hofman, JH Woods, G Winger. Depressants of the central nervous system: alcohol, barbiturates, and benzodiazepines. In: A Handbook of Drug and Alcohol Abuse: Biomedical Aspects. 3rd ed. New York: Oxford University Press, 1992.
105. H Isbell, S Altschul, CH Kormetsky, AJ Eisenman, HG Flanary, HF Fraser. Chronic barbiturate intoxication. Arch Neurol Psychiatry 64: 1-28, 1950.
106. RT Owen, P Tyrer. Benzodiazepine dependence: a review of the evidence. Drugs 25: 385-398, 1983.
107. PR Martin, BM Kapur, EA Whiteside, EM Sellers. Intravenous phenobarbital therapy in barbiturate and other hypnosedative withdrawal reactions: a kinetic approach. Clin Pharmacol Ther 26: 256-264, 1979.
108. PL Hoffman, KA Grant, LD Snell, L Reinlib, K Iorio, B Tabakoff. NMDA receptors: role in ethanol withdrawal seizures. Ann NY Acad Sci 654: 52-60, 1992.
109. MA Whittington, JDC Lambert, HJ Little. Increased NMDA receptor and calcium channel activity underlying ethanol withdrawal hyperexcitability. Alcohol Alcohol 30: 105-114, 1995.
110. MF Mayo-Smith. Pharmacological management of alcohol withdrawal: a metaanalysis and evidence-based practice guideline. JAMA 278: 144-151, 1997.
111. RH Lohr. Treatment of alcohol withdrawal in hospitalized patients. Mayo Clin Proc 70: 777-782, 1995.
112. J Ballenger, R Post. Carbanazepine in alcohol withdrawal syndromes and schizophrenic psychoses. Psychopharmacol Bull 20: 572-584, 1984.
113. M Brown, R Anton, R Malcom, JC Ballenger. Alcohol detoxification and withdrawal seizures: clinical support for a kindling hypothesis. Biol Psychiatry 23: 507-514, 1988.
114. DA Greenberg. Ethanol and sedatives. In: Neurologic Complications of Drug and Alcohol Abuse. Neurol Clin 11: 523-534, 1993.
115. PR Martin, DM Lovinger, GR Breese. Alcohol and other abused substances. In: P Munson, RA Mueller, GR Breese, eds. Principles of Pharmacology: Basic concepts and clinical applications. New York: Chapman & Hall, pp 417-452, 1995.
116. MA Schuckit. Drug and Alcohol Abuse. 4th ed. New York: Plenum Medical, 1995.
117. BK Alldredge, DH Lowenstein, RP Simon. Seizures associated with recreational drug abuse. Neurology 39: 1037-1039, 1989.
118. DH Lowenstein, SM Massa, MC Rowbotham, SD Collins, HE McKinney, RP Simon. Acute neurologic and psychiatric complications associated with cocaine abuse. Am J Med 83: 841-846, 1987.
119. E Brown, J Prager, HY Lee, RG Ramsey. CNS complications of cocaine abuse: prevalence, pathophysiology, and neuroradiology. Am J Roentgenol 159: 137-147, 1992.
120. M Choy-Kwong, RB Lipton. Seizures in hospitalized cocaine users. Neurology 39: 425-427, 1989.
121. A Pascual-Leone, A Dhuna, I Altafullah, DC Anderson. Cocaine-induced seizures. Neurology 40: 404-407, 1990.
122. RL Rodnitzky, DL Keyser. Neurologic complications of drugs: tardive dyskinesias, neuroleptic malignant syndrome, and cocaine-related syndromes. Psychiatr Clin North Am 15: 491-510, 1992.
123. JCM Brust. Cocaine. In: Neurological Aspects of Substance Abuse. Woburn, MA: Butterworth-Heinemann, 1993.
124. HC Jacobson, DM Ball, DJ Nutt. Noradrenergic mechanisms appear not to be involved in cocaine-induced seizures and lethality. Life Sci 47: 353-359, 1990.
125. J Zhai, SJ Wieland, FM Sessler. Chronic cocaine intoxication alters hippocampal sodium channel function. Neurosci Lett 229: 121-124, 1997.
126. RM Post, SRB Weiss, A Pert. Cocaine-induced behavioral sensitization and kindling: implications for the emergence of psychopathology and seizures. In: The Mesocorticolimbic Dopamine System. PW Kalivas, CB Nemeroff, eds. Ann NY Acad Sci 537: 292-308, 1988.
127. Y Itzhak, I Stein. Sensitization to the toxic effects of cocaine in mice is associated with the regulation of N-methyl-D-aspartate receptors in the cortex. J Pharmacol Exp Ther 262: 464-470, 1992.
128. Y Itzhak. Cocaine kindling in mice. Mol Neurobiology 11: 217-222, 1995.
129. KA Olson, TE Kearney, JE Dyer, NL Benowitz, PD Blanc. Seizures associated with poisoning and drug overdose. Am J Emerg Med 11: 565-568, 1993.
130. RW Derlet, P Rice, BZ Horowitz, RV Lord. Amphetamine toxicity: experience with 127 cases. J Emerg Med 7: 157-161, 1989.
131. HI Kaplan, BJ Sadock, JA Grebb. Kaplan and Sadock’s Synopsis of Psychiatry: Behavioral Sciences, Clinical Psychiatry. 7th ed. Baltimore: Williams and Wilkins, 1994.
132. TB Borowski, RD Kirby, L Kokkinidis. Amphetamine and antidepressant drug effects on GABAA- and NMDA-related seizures. Brain Res Bull 30: 607-610, 1993.
133. KK Jain. Drug-Induced Neurological Disorders. Seatlle, WA: Hogrefe and Huber, 1996.
134. SKC Ng, JC Brust, WA Hauser, M Susser. Illicit drug use and the risk of new-onset seizures. Am J Epidemiol 132: 47-57, 1990.
135. PJ Armstrong, A Bersten. Normeperidine toxicity. Anesth Analg 65: 536-538, 1986.
136. LR Caplan, C Thomas, G Banks. Central nervous system complications of addiction to “T’s and Blues.”. Neurology 32: 623-628, 1982.
137. ES Freedland, DB McMicken. Alcohol-related seizures. I. Pathophysiology, differential diagnosis, and evaluation. J Emerg Med 11: 463-473, 1993.
138. ES Freedland, DB McMicken. Alcohol-related seizures. II. Clinical presentation and management. J Emerg Med 11: 605-618, 1993.
139. A Jagoda, L Richardson. The evaluation and treatment of seizures in the emergency department. Mt Sinai J Med 64: 249-257, 1997.
140. DE Grobbee, PJ Koudstaal, ML Bots, LA Amaducci, PC Elwood, J Ferro, A Freire de Concalves, O Kruger, D Inzitari, Y Nikitin, JT Salonen, J Sivenius, W Scheuermann, DS Thelle, A Trichopoulou, JT Tuomilehto. Incidence and risk factors of ischemic and haemorrhagic stroke in Europe. Neuroepidemiology 15: 291-300, 1996.
141. K-T Khaw. Epidemiology of stroke. J Neurol Neurosurg Psychiatry 61: 333-338, 1996.
142. R Shinton, G Beevers. Meta-analysis of relation between cigarette smoking and stroke. Br Med J 298: 789-794, 1989.
143. NL Benowitz. Pharmacologic aspects of cigarette smoking and nicotine addiction. N Engl J Med 319: 1318-1330, 1988.
144. S Renaud, D Blanche, E Dumont, C Thevenon, T Wissendanger. Platelet function after cigarette smoking in relation to nicotine and carbon monoxide. Clin Pharmacol Ther 36: 389-395, 1984.
145. K Kubota, T Yamaguchi, Y Abe, T Fujiwara, J Hatazawa, T Matsuzawa. Effects of smoking on regional cerebral blood flow in neurologically normal subjects. Stroke 14: 720-724, 1983.
146. JW Davis, L Shelton, DA Eigenberg, CE Hignite, IS Watanabe. Effects of tobacco and non-tobacco cigarette smoking on endothelium and platelets. Clin Pharmacol Ther 37: 529-533, 1985.
147. JD Morrow, B Frei, AW Longmire, JM Goziaro, SM Lynch, Y Shyr, WE Strauss, JA Oates, LJ Roberts II. Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. N Engl J Med 332: 1198-1203, 1995.
148. T Shishido, R Suzuki, L Qian, K Hirakawa. The role of superoxide anions in the pathogenesis of cerebral vasospasm. Stroke 25: 864-868, 1994.
149. R Fogelholm, K Murros. Cigarette smoking and subarachnoid hemorrhage: a population-based case-control study. J Neurol Neurosurg Psychiatry 50: 78-80, 1987.
150. S Junela, M Hillbom, H Palomaki. Risk factors for spontaneous intracerebral hemorrhage. Stroke 26: 1558-1564, 1995.
151. SG Wannamethee, AG Shaper. Patterns of alcohol intake and risk of stroke in middle-aged British men. Stroke 27: 1033-1039, 1996.
152. CA Camargo. Moderate alcohol consumption and stroke: the epidemiologic evidence. Stroke 20: 1611-1626, 1989.
153. M Hillbom, M Kaste. Ethanol intoxification: a risk factor for ischemic brain infarction. Stroke 14: 694-699, 1983.
154. PB Gorelick. Alcohol and stroke. Stroke 18: 268-271, 1987.
155. WT Longstraeth Jr, TD Koepsell, MS Yerby, G Van Belle. Risk factors for subarachnoid hemorrhage. Stroke 16: 377-385, 1985.
156. JM MacKenzie. Intracerebral hemorrhage. J Clin Pathol 49: 360-364, 1996.
157. DA Kaku, DH Lowenstein. Emergence of recreational drug abuse as a major risk factor for stroke in young adults. Ann Intern Med 113: 821-827, 1990.
158. SR Levine, JCM Brust, N Futrell, LM Brass, D Blake, P Fayad, LR Shultz, CH Millikan, KL Ho, KM Welch. A comparative study of the cerebrovascular complications of cocaine: alkaloidal versus hydrochloride-a review. Neurology 41: 1173-1177, 1991.
159. G Bartzokis, M Beckson, W Ling. Clinical and MRI evaluation of psychostimulant neurotoxicity. In: Neurotoxicity and Neuropathology Associated with Cocaine Abuse. MD Majewska, ed. Rockville, MD: NIDA Research Monograph 163, 1996.
160. N Martinez, E Diez-Tejedor, A Frank. Vasospasm/thrombus in cerebral ischemia related to cocaine abuse [letter]. Stroke 27: 147-148, 1996.
161. JP Konzen, SR Levine, JH Garcia. Vasospasm and thrombus formation as possible mechanisms of stroke related to alkaloidal cocaine. Stroke 26: 1114-1118, 1995.
162. K Kibayashi, A Mastri, C Hirsch. Cocaine induced intracerebral hemorrhage: analysis of predisposing factors and mechanisms causing hemorrnagic strokes. Hum Pathol 26: 659-663, 1995.
163. L Caplan. Intracerebral hemorrhage revisited. Neurology 38: 624-627, 1988.
164. JR Mangiardi, M Daras, ME Geller, I Weitzner, AJ Tuckman. Cocaine related intracranial hemorrage: report of nine cases and review. Acta Neurol Scand 77: 177-180, 1988.
165. CM Sauer. Recurrent embolic stroke and cocaine-related cardiomyopathy. Stroke 22: 1203-1205, 1991.
166. MM El-Omar, K Ray, R Geary. Intracerebral haemorrhage in a young adult: consider amphetamine abuse. Br J Clin Pract 50: 115-116, 1996.
167. DJ Yen, SJ Wang, TH Ju, CC Chen, KK Liao, JL Fuh, HH Hu. Stroke associated with methamphetamine inhalation. Eur Neurol 34: 16-22, 1994.
168. A Bruno, KB Nolte, J Chapin. Stroke associated with ephedrine use. Neurology 43: 1313-1316, 1993.
169. BT Altura, BM Altura. Phencyclidine, lysergic acid diethylamide, and mescaline: cerebral artery spasms and hallucinogenic activity. Science 212: 1051-1052, 1981.
170. MJ Parker, MJ Tarlow, JM Anderson. Glue sniffing and cerebral infarction. Arch Dis Child 59: 675-677, 1984.
171. JCM Brust, RW Richter. Stroke associated with addiction to heroin. J Neurol Neurosurg Psychiatry 39: 194-199, 1976.
172. TR Kosten. Pharmacotherapy of cerebral ischemia in cocaine dependence. Drug Alcohol Depend 49: 133-144, 1998.
173. DM Kaufman. Involuntary movement disorders. In: Clinical Neurology for Psychiatrists. 4th ed. Philadelphia: WB Saunders, 1995.
174. RD Adams, M Victor. Abnormalities of movement and posture due to disease of the extrapyramidal motor systems. In: Principles of Neurology. 5th ed. New York: McGraw-Hill, 1993.
175. J Neiman, AE Lang, L Fornazzari, PL Carlen. Movement disorders in alcoholism: a review. Neurology 40: 741-746, 1990.
176. F Cardoso, J Jankovic. Movement disorders: neurologic complications of drug and alcohol abuse. Neurologic Clin 11: 625-638, 1993.
177. JH Darden, WA Hunt. Reduction of striatal dopamine release during an ethanol withdrawal syndrome. J Neurochem 29: 1143-1145, 1977.
178. S Liljequist. Changes in the sensitivity of dopamine receptors in the nucleus accumbens and in the striatum induced by chronic ethanol administration. Acta Pharmacol Toxicol 43: 19-28, 1978.
179. H Lai, MA Carino, A Horita. Effects of ethanol on central dopamine functions. Life Sci 27: 299-304, 1980.
180. J Balldin, C Alling, CG Gottfries, G Lindstedt, G Langstrom. Changes in dopamine receptor sensitivity in humans after heavy alcohol intake. Psychopharmacology 86: 142-146, 1985.
181. I Smolders, N DeKlippel, S Sarre, G Ebinger, Y Michotte. Tonic GABAA-ergic modulation of striatal dopamine release studied by in vivo microdialysis in the freely moving rat. Eur J Pharmacol 284: 83-91, 1995.
182. FEC Cardoso, J Jankovic. Cocaine-related movement disorders. Mov Disord 8: 175-178, 1993.
183. MM Mesulam. Cocaine and Tourette’s syndrome [letter]. N Engl J Med 315: 398, 1986.
184. SA Factor, JR Sanchez-Ramos, WJ Weiner. Cocaine and Tourette’s syndrome [letter]. Ann Neurol 23: 423-424, 1988.
185. A Pascual-Leone, A Dhuna. Cocaine-associated multifocal tics. Neurology 40: 999-1000, 1990.
186. M Daras, BS Koppel, E Atos-Radzion. Cocaine-induced choreoathetoid movements (“crack dancing”). Neurology 44: 751-752, 1994.
187. J Merab. Acute dystonic reaction to cocaine [letter]. Am J Med 84: 564, 1988.
188. D Rebischung, M Daras, AJ Tuchman. Dystonic movements associated with cocaine use [abstr]. Ann Neurol 28: 266, 1990.
189. M Choy-Kwong, RB Lipton. Dystonia related to cocaine withdrawal: a case report and pathogenic hypothesis. Neurology 39: 996-997, 1989.
190. K Kumor. Cocaine withdrawal dystonia [letter]. Neurology 40: 863, 1990.
191. SL Satel, AL Swann. Extrapyramidal symptoms and cocaine abuse [letter]. Am J Psychiatry 150: 347, 1993.
192. K Kumor, M Sherer, J Jaffe. Haloperidol-induced dystonia in cocaine addicts [letter]. Lancet ii: 1341-1342, 1986.
193. AM Hegarty, RB Lipton, AE Merriam, K Freeman. Cocaine as a risk factor for acute dystonic reactions. Neurology 41: 1670-1672, 1991.
194. JM Wilson, AI Levey, C Bergeron, K Kalasinsky, L Ang, F Peretti, VI Adams, J Smialek, WR Anderson, K Shannak, J Deck, HB Niznik, SJ Kish. Striatal dopamine, dopamine transporter, and vesicular monoamine transporter in chronic cocaine users. Ann Neurol 40: 428-439, 1996.
195. GW Ashcroft, D Eccleston, JL Waddell. Recognition of amphetamine addicts [letter]. Br Med J 1: 57, 1965.
196. HL Klawans, WJ Weiner. The effect of D-amphetamine on choreiform movement disorders. Neurology 24: 312-318, 1974.
197. H Lundh, K Tunving. An extrapyramidal choreiform syndrome caused by amphetamine addiction. J Neurol Neurosurg Psychiatry 44: 728-730, 1981.
198. LS Sperling, JL Horowitz. Methamphetamine-induced choreoathetosis and rhabdomyolysis [letter]. Ann Intern Med 121: 986, 1994.
199. LS Seiden, KE Sabol. Methamphetamine and methylenedioxymethamphetamine neurotoxicity: possible mechanisms of cell destruction. In: Neurotoxicity and Neuropathology Associated with Cocaine Abuse. MD Majewska, ed. Rockville, MD: NIDA Research Monograph 163, 1996.
200. S Przedborski, V Jackson-Lewis. Mechanisms of MPTP toxicity. Mov Disord 13: 35-38, 1998.